Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barco
Voxar Colonscreen receives FDA clearance for patient screening
April 10th, 2005
Barco announced that it has received 510(k) premarket clearance from the U.S. Food and Drug Administration (FDA) for Voxar Colonscreen, the company's CT colonography software application. Voxar Colonscreen is now cleared for both the examination of symptomatic patients and the screening of asymptomatic patients for the detection of colonic polyps, tumors and other lesions. The 510(k) clearance for Voxar Colonscreen is an important step forward. The ability to use Voxar Colonscreen as a screening tool for the detection of colon cancer allows medical institutions to offer CT colonography programs to the general public at large. Early detection and...
Source: Aging & Elder Health Week (2005-04-10)
|
